January 4, 2018 / 12:40 PM / 9 months ago

BRIEF-Spero Therapeutics Appoints David Melnick As Chief Medical Officer

Jan 4 (Reuters) - Spero Therapeutics Inc:

* SPERO THERAPEUTICS APPOINTS DAVID MELNICK, M.D., AS CHIEF MEDICAL OFFICER

* SPERO THERAPEUTICS INC - ‍PRIOR TO JOINING CO, MELNICK SERVED AS VICE PRESIDENT OF CLINICAL DEVELOPMENT FOR ANTI-INFECTIVES AT ALLERGAN SINCE 2015​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below